SYRE
Spyre Therapeutics Inc.
87.10$
-1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.40 | -24.02 | -48.10 | -40.68 | -38.65 | -51.40 | -35.49 | -20.43 | -23.77 | -14.49 | -3.35 | -2.64 | |
| 0.03 | 0.19 | 0.34 | 0.41 | 0.35 | 0.71 | 0.47 | 0.60 | 0.46 | 0.11 | 0.02 | -0.13 | |
| 0.27 | 1.68 | – | – | – | 4.30 | 2.93 | 3.06 | 2.11 | 3.72 | 0.95 | 0.59 | |
| 0.05 | -2.92 | 3.70 | -0.33 | 8.65 | 5.56 | -1.19 | 0.70 | -1.63 | -0.75 | -0.10 | -0.09 | |
| 0.33 | 0.45 | 0.54 | 1.02 | 0.51 | 1.17 | 2.00 | 0.22 | 0.01 | 0.00 | 0.00 | 0.00 | |
| -0.40 | -8.78 | -31.04 | -37.23 | -18.29 | -1.36 | -3.56 | -8.60 | 16.91 | – | -7.51 | -2.24 | |
| – | -4.44 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -0.19 | -0.12 | 0.00 | 0.00 | – | |
| 10.19 | 91.15 | 126.05 | 20.18 | 68.52 | 51.43 | 72.38 | 0.53 | 12.66 | 52.35 | 8.74 | 4.82 | |
| -3.62 | 58.35 | 46.91 | -57.73 | 11.58 | -2.51 | 33.34 | -28.50 | 5.77 | 22.15 | -2.12 | -0.06 | |
| -13.74 | -24.48 | -48.64 | -41.70 | -39.16 | -52.57 | -37.50 | -20.64 | -23.78 | -14.49 | -3.35 | -2.64 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.